title: [Efficacy and tolerance of allergenic extracts Allergovit and Novo-Helisen depot in immunotherapy of allergic diseases].
abstract: The aim of this study was to evaluate the efficacy, tolerance and immunogenity of allergenic extracts: Allergovit and Novo-Hellisen depot (produced by Allergopharma--Germany), used for sIT in pollinosis and house dust mite allergy. The treatment was carried out on 40 patients for three years. The evaluation included the results of a physical examination, the score of symptoms from self-observations and the consumption of antiallergic medicines. In addition to the serum IgE and IgG4 the percentage of histamine, liberated by a-IgE and specific allergens, from peripheral blood basophils was determined. In some of patients treated with Novo-Helisen depot the specific and nonspecific bronchial challenge tests were made. It was shown that the allergenic extracts Allergovit and Novo-Helisen depot are effective in treatment of pollinosis and house dust mite allergy, and are well tolerated by the patients. The changes in humoral response during sIT manifest their immunogenity. The sIT with Allergovit decreases the sensitivity of the peripheral blood basophils, whereas the treatment with Novo-Helisen depot causes a diminution of bronchial specific and nonspecific reactivity and a negativisation of late allergic reaction.
authors.affiliation: Kliniki Alergologii Akademii Medycznej w Białymstoku.
authors.forename: S
authors.initials: S
authors.lastname: Chyrek-Borowska
authors.forename: A
authors.initials: A
authors.lastname: Rogalewska
authors.forename: W
authors.initials: W
authors.lastname: Szymański
authors.forename: I
authors.initials: I
authors.lastname: Złotnik
authors.forename: I
authors.initials: I
authors.lastname: Michalska
mesh_terms: D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000276:immunology; D001249:Asthma / Q000276:immunology / Q000628:therapy*; D001491:Basophils / Q000276:immunology; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007167:Immunotherapy; D008297:Male; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000628:therapy*; D014612:Vaccines; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D010936:Plant Extracts; D014612:Vaccines; D014614:Vaccines, Synthetic; C099681:allergovit; D007073:Immunoglobulin E; C014135:Novo-Helisen Depot